A randomized, open-label, multicenter, 4-week study to evaluate the tolerability and pharmacokinetics of ITCA 650 in patients with type 2 diabetes
The STEP trials showed continued weight loss improvement at higher doses, with the dose-response relationship remaining positive through 2.4 mg
To me, this shows that they arent interested in keeping patients sick for perpetual profit, but rather healing people at a level that is hard to achieve in our current society
For patients with gastroparesis, however, further slowing of already-delayed gastric emptying may worsen symptoms like nausea, vomiting, early fullness, and bloating
Semaglutide in obesity: unmet needs in men
c ch sc t melanin gy ra vt thm, nm, tn nhang